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The linear form of Epstein-Barr virus (EBV) DNA has homologous direct tandem repeats of approximately
500 bp at each terminus (TR). After infection, EBV DNA circularizes via the TR to form the intracellular
episomal DNA. To analyze the mechanism of the synthesis of linear DNA through possible replicative
intermediates, the terminal fragments were identified in the total intracellular DNA and the covalently closed
circular DNA from a productively infected cell line after induction of replication or after treatment with an
inhibitor of viral DNA synthesis. These studies indicate that some of the fused terminal fragments detected in
the total intracellular DNA are replication-dependent forms which are selectively excluded from the covalently
closed circular fraction and are eliminated after treatment with acyclovir. The EBV terminal restriction
enzyme fragments were identified in three producer cell lines, each with a characteristic number of TR in the
intracellular episomal DNA. Identification of the termini in cell lines established with the three virus strains
revealed that the newly transformed cell lines had a greater number of TR than did the template DNA in the
producer cell line. The increase in the number of TR in progeny episomes indicates that linear DNA is produced
from concatameric replicative intermediates rather than from amplified catenated circular intermediates.
In the nonreplicative phase of infection, intracellular Ep-
stein-Barr virus (EBV) DNA exists as an covalently closed
circular (CCC) episome (18, 21). After induction of replica-
tion, the episomal DNA seems to serve as template for
generation of the linear, virion DNA, which is synthesized
by a virus-specific DNA polymerase, in contrast to the
episomal form (8, 10, 21). Treatment of virus-producer cell
lines with phosphonoacetic acid or acyclovir (ACV), specific
inhibitors of EBV polymerase, greatly reduces the abun-
dance of viral DNA; however, a small portion of the viral
DNA in cell lines is resistant to inhibition by PAA and ACV
and consists of CCC DNA (5, 6, 8, 29, 33). The inhibitors of
the viral DNA polymerase also do not decrease the abun-
dance of EBV DNA in cell lines that do not produce virus
and that contain only episomal DNA, indicating that EBV
episomal DNA is maintained by the host cellular DNA
polymerase (5, 18). An origin of replication that confers the
ability to be maintained episomally in the presence of an
EBV gene product, EBNA1, has been identified (35).
Productive replication of the EBV genome may result
from amplification of the episome, generating catenated,
linked circles that are subsequently cleaved into the linear
form. Alternatively, replication may occur through a rolling-
circle or concatenated replicative intermediate (RI). A lytic
origin of replication (orilyt) has been identified in the EBV
genome (12). In permissively infected cell lines, plasmids
containing these sequences are amplified in concatenated
form after induction of EBV replication, suggesting that
EBV may also be replicated via a concatenated RI. Pulse-
field electrophoretic analyses of permissively infected cells
revealed higher-molecular-weight forms that could reflect
concatenated RI or topologically linked amplified circular
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DNA (J. Kolman and G. Miller, Abstr. Inc. Symp. EBV
Assoc. Malig. Dis., p. 8, 1988).
EBV DNA has homologous direct tandem repeats of
approximately 500 bp at each terminus (TR) (1, 7, 9, 17). In
preparations of virion DNA, the terminal restriction endo-
nuclease fragments are heterogeneous in size, varying by
increments of 500 bp (9, 17). After infection, the linear
termini join to form covalently closed episomal DNA. Vari-
ability in the number of TR at each linear terminus of EBV
virion DNA generates fused termini after circularization that
also contain variable numbers of TR (4, 7, 17, 22, 23).
Analysis of the terminal restriction enzyme fragments of
EBV revealed that in monoclonal cell lines and EBV-
infected malignancies, the EBV DNA was clonal, with a
homogeneous number ofTR in the fused terminal restriction
enzyme fragment representing the episomal DNA (3, 4, 23).
The clonality of EBV genomes indicated, by extension,
cellular monoclonality (23). In addition, the structure of the
EBV termini provided evidence for viral replication, as
indicated by the appearance of ladder arrays of terminal
fragments representing linear forms of EBV DNA (14, 23).
Evidence of linear arrays have also been detected in vivo in
many lymphoproliferations (14).
In this study, to distinguish terminal fragments represent-
ing the template DNA, potential RI, and progeny linear
DNA, the terminal fragments were identified in total intra-
cellular DNA and in CCC DNA from virus-producer cell
lines after induction of replication and after treatment with
an inhibitor of viral replication. These analyses revealed that
the CCC form contained a homogeneous number of TR and
was detected as a single fused terminal restriction enzyme
fragment. After induction of replication, fused terminal
fragments were amplified in the total intracellular DNA but
were not amplified in the CCC DNA fraction. These data
indicate that some of the fused terminal fragments present in
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total intracellular DNA represent replication-dependent
forms.
This analysis revealed that a given producer cell line has a
constant number of TR in the template episomal DNA.
Therefore, determination of the number of TR that are
present in the linear progeny DNA arising from a specific
template could clarify the form of the RI. If EBV DNA is
amplified as a catenated circle, cleavage into the linear form
within one or more TR would generate linear forms with
variable numbers of TR at each terminus. Infection of new
cells with this virus would generate episomal DNAs with
fewer or the same number of TRs as are in the template
DNA. In contrast, if the episome is amplified via a concat-
enated RI, then random cleavage within the TR could
generate after infection progeny episomes that contain all
possible numbers of TR, ranging from a few to almost twice
that in the parental template. To assess the total number of
TR in linear progeny, the fused terminal fragments were
identified in cell lines established by infection in vitro with
virus produced from three cell lines with a known, constant
number of TR in the episomal DNA. These studies revealed
that in each case, progeny molecules that contained the full
possible range of copies of TR were synthesized. The range
in variation in the number of TR was proportional to the
number of TR in the template DNA, with the maximum
number of TR in the progeny molecules approaching twice
that in the parental template. The generation of progeny
molecules with increased numbers of TR suggests that EBV
replicates as a concatenated RI.
MATERIALS AND METHODS
Cell lines, virus purification, and infection in vitro. The
B95-8 and AG876 lymphoid cell lines were maintained in
RPMI-10% fetal calf serum. The NPC-KT, and A2L/AH cell
lines were maintained in Dulbecco modified Eagle medium
supplemented with 5% fetal calf serum. B95-8 and AG876
are partially permissive cell lines that were induced to
greater permissivity by treatment for 7 days with 20 ng of
12-O-tetradecanoylphorbol-13-acetate (TPA) per ml (Sigma
Chemical Co., St. Louis, Mo.) (19, 36). The EBV-positive
NPC-KT cell line is an epithelial hybrid cell line established
by fusion of a primary nasopharyngeal carcinoma tissue with
an adenoidal epithelial cell line, AD/AH (30, 31). A2L/AH is
an epithelial hybrid cell line produced by fusion of AD/AH
with a lymphoblastoid cell line established by infection with
B95-8 virus (32). Virus production was induced in the
NPC-KT and A2L/AH cell lines by treatment with 60 ,ug of
5-iodo-2"-deoxyuridine (IUdR) per ml for 3 days, followed
by 3 days of culture without IUdR.
Virus replication was inhibited in the producer cell lines
by treatment with 100 ,uM ACV (5, 6). Intracellular DNA
was extracted from total cellular lysates or CCC DNA
prepared after alkaline extraction (11, 23).
Lymphocytes were purified from neonatal umbilical cord
blood or from adult peripheral blood after centrifugation
through a Ficoll step gradient. The nonadherent mononu-
clear cells were infected with supernatant from the induced
NPC-KT, AG876, or A2L/AH cell line and cultured for 3 to
4 weeks in vitro. Peripheral blood lymphocytes were cul-
tured in the presence of 2 ng of cyclosporin A per ml (34).
Identification of the EBV termini. EBV intracellular or
virion DNAs were digested with BamHI, subjected to elec-
trophoresis through a 0.6% agarose gel, and transferred to
nitrocellulose. The right-terminal BamHI fragments were
identified by hybridization with a 32P-labeled single-stranded
RNA probe synthesized from a 1.9-kb XhoI fragment cloned
into the pGEM2 vector (Promega, Madison, Wis.), using
SP6 polymerase (23). This fragment represents unique DNA
adjacent to the terminal repeats at the right end of the
genome. The left-terminal restriction enzyme fragments
were identified by using the EcoRI-BamHI portion of the
EcoRI I fragment, representing unique DNA adjacent to the
terminal repeats at the left end of the genome, labeled with
32P by nick translation (23, 24).
RESULTS
Identification of terminal fragments during replication. To
identify and distinguish the terminal fragments representing
the episomal DNA from terminal fragments in RI and
progeny DNA, the terminal fragments of the B95-8 strain of
EBV were identified. The right-terminal BamHI fragment of
B95-8 EBV contains approximately 3.5 kb of unique DNA
and varying numbers of TR, whereas the left-terminal
BamHI terminus of EBV contains approximately 4 kb of
unique DNA with multiple copies of TR (1, 7, 23). The fused
terminal fragments, which contain 7.5 kb of unique DNA,
can be identified by their larger size and will hybridize to
probes representing unique DNA from either end of the
genome (23).
Southern blots were prepared with total intracellular and
CCC DNA digested with BamHI from B95-8 cells that were
untreated or treated with TPA, ACV, or TPA plus ACV for
7 days. The filters were hybridized to recombinant single-
stranded RNA or DNA probes representing unique DNA
sequences adjacent to the repeat sequences from the left or
right end of the EBV genome (Fig. 1). As reported previ-
ously, multiple fused terminal fragments were identified with
the probes from the left and right termini, which ranged in
size from 8.9 to 10.4 kb (4, 23). A ladder of fragments
representing linear termini was also detected in the total
intracellular DNA from uninduced or TPA-treated B95-8
cells. After treatment with ACV, an inhibitor of the EBV-
encoded DNA polymerase, most of these fragments were
greatly reduced, with a predominant single 10.4-kb fused
terminal fragment remaining. These results indicated that the
multiple fused terminal fragments and the linear arrays of
terminal fragments were synthesized by the viral DNA
polymerase and were replication-dependent forms. The viral
DNA, which was resistant to ACV treatment and has been
previously shown to consist of CCC DNA, contained homo-
geneous viral DNA with a constant number of TR.
To confirm that the endogenous episomal DNA contained
a constant number of TR, CCC DNA was selectively ex-
tracted. This DNA fraction also contained a single 10.4-kb
fused terminal fragment whose abundance was largely unaf-
fected by induction of replication with TPA or treatment
with ACV (Fig. 1) (11). Consistently high background in the
lane containing CCC DNA from TPA-induced cells was
probably due to contaminating small, single-stranded DNA
fragments from the nicked viral DNA, characteristic of
herpes virion DNA (16). These results confirmed that in
B95-8 cells, the CCC episomal DNA which is maintained by
the cellular enzyme contains a homogeneous number of TR
and that the abundance of the episomal DNA is unaffected
by induction or inhibition of viral replication.
In contrast, in the total intracellular DNA, heterogeneous
fused termini ranging in size from 8.9 to 10.4 kb were
detected. These fragments increased after induction of rep-
lication and were greatly reduced by treatment with ACV.
These additional fused terminal fragments therefore must be
J. VIROL.
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FIG. 1. Analysis of EBV termini in intracellular and CCC DNAs from B95-8 cells. B95-8 cells were untreated (N), induced by 20 ng ofTPA
per ml (T), treated with 100 ,uM ACV (A), or incubated with TPA plus ACV for 7 days (T + A). A Southern blot, prepared with intracellular
DNA (5 ,ug) and CCC DNA from 2 x 106 cells digested with BamHI, was hybridized to the 32P-labeled RNA transcribed with SP6 polymerase
from the XhoI 1.9-kb fragment representing unique DNA adjacent to the right-terminal repeats (RIGHT). After autoradiography, the
nitrocellulose filter was treated with boiling water to remove the XhoI probe and rehybridized to an EcoRI-I probe labeled with 32P by nick
translation. This probe represents unique DNA adjacent to left-terminal repeats (LEFT).
synthesized by the viral DNA polymerase and represent
replication-dependent forms. Fused terminal fragments that
were smaller than the template DNA were also detected in
the HR-1 cell line after induction with butyrate (14). These
new forms with differing numbers of TR may represent RI
formed from progeny DNA.
Analysis of template DNA and episomal DNA produced by
infection with progeny virion DNA. These data indicated that
the homogeneous episomal DNA is a template for the
generation of replication-depqndent forms which are ampli-
fied by the viral DNA polymerase. These forms included
virion DNA represented by ladder arrays of terminal restric-
tion enzyme fragments and increased fragments representing
fused termini. Since each EBV-infected cell line has a
characteristic number of TR, analysis of the total number of
TR in the progeny DNA molecules should elucidate the form
of the RI. Random cleavage within any of the copies of TR
in a concatameric linear template containing four copies of
TR would produce progeny molecules whose total number of
TR could vary between two and six (Fig. 2). If the template
DNA contained 8 copies of TR, the variation in the number
of TR in the progeny molecules would increase and could
vary from 2 to 14.
Analysis of the EBV terminal fragments after infection
with EBV produced by the nasopharyngeal carcinoma hy-
brid cell line (NPC-KT) revealed that NPC-KT virus effi-
ciently circularizes or forms concatamers (25-27). The re-
striction terminal fragment(s) of episomal DNA in NPC-KT
cells was identified on Southern blots prepared with intra-
cellular DNA digested with BamHI from untreated NPC-KT
cells and cells treated with IUdR to induce viral replication.
Hybridization with the XhoI 1.9-kb probe representing the
unique DNA from the right terminus identified a single
9.4-kb fragment in mock-treated NPC-KT cells which would
contain four copies of TR (Fig. 3). In IUdR-induced cells, in
addition to an amplified 9.4-kb fused fragment, a ladder of
linear termini was identified. Hybridization with the EcoRI-I
probe representing unique DNA from the left terminus also
identified the single 9.4-kb fragment in mock-treated cells
TR: 4
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FIG. 2. Concatameric replication of EBV: variation of numbers
ofTR in episomal forms in virus-producer cells and in infected cells.
The top line shows the synthesis and cleavage of concatemeric
DNA; the middle line shows the progeny linear forms with variable
numbers of TR; the bottom line shows the progeny circular forms
that would be produced from a concatameric template containing




5298 SATO ET AL.
~P vi





FIG. 3. Variation of numbers of EBV TR in NPC-KT cells and
neonatal lymphocytes transformed by the virus from NPC-KT cells.
Neonatal lymphocytes were infected with the virus from NPC-KT
cells and cultured for 4 weeks. A Southern blot was prepared from
the intracellular DNAs (2.5 Rg), digested with BamHI, from un-
treated cells (lane Non), from lUdR-induced NPC-KT cells (lane
IUdR), and from cord blood lymphocytes transformed by the virus
from NPC-KT cells (lane CBL). The blot was hybridized to the XhoI
1.9-kb probe for the EBV right-terminal fragment.
and a ladder of linear forms and an amplified 9.4-kb fragment
in IUdR-induced cells (data not shown). Amplification of the
9.4-kb fused fragment after induction of virus replication
suggested that this fragment represents the intermediate for
the synthesis of linear DNA.
The fused termini that were formed upon transformation
of lymphoblastoid cells with NPC-KT virus were character-
ized. The fused terminal fragments produced by infection
with NPC-KT virus were identified in cord blood lympho-
cytes transformed by the virus and ranged in size from 8.4 to
10.4 kb (Fig. 3). These fused terminal fragments would
contain between two and six copies of the TR, identical to
the number predicted by the model in Fig. 2.
The structure of termini was also characterized in the
virus-producer lymphoid cell line AG876. A single fused
11.5-kb fragment containing eight copies of TR was identi-
fied in AG876 cells treated with ACV (Fig. 4). The single
11.5-kb fused fragment was amplified after induction of
replication. The right-terminal fragments in the purified
virion DNA preparations ranged in size from 4.2 to 11.5 kb,
which would contain two to eight copies of TR. Mononu-
clear lymphoid cells purified from umbilical cord blood or
adult peripheral blood lymphocytes were infected with
AG876 virus. The EBV terminal fragments were identified in
the total intracellular DNA 3 to 4 weeks after infection. The
AG876 linear virion DNA circularized after infection of
neonatal lymphocytes and adult peripheral blood lympho-
blastoid cells to form predominant fused terminal fragments
that varied in size from 9.5 to 13.5 kb, representing 4 to 12
copies of TR. A ladder of fragments representing the mixture
of linear and fused termini ranging in size from 4.2 to 13.5 kb
was also detected, indicating that the cell lines were partially
permissive for EBV replication.




FIG. 4. Variation in numbers of EBV TR in AG876 cells and
lymphoblastoid cells transformed by the virus from AG876 cells.
Cord blood lymphocytes and peripheral blood lymphocytes from an
EBV-seropositive person were infected with AG876 virus and were
cultured for 3 weeks in the absence and presence, respectively, of
cyclosporin A (2 ng/ml). Virion DNA (10 ng) (lane Virion) and
intracellular DNAs (2.5 p.g) from ACV-, TPA-, and untreated AG876
cells and from cord blood lymphocytes and peripheral blood lym-
phocytes transformed by virus from AG876 cells (lanes ACV, TPA,
Non, CBL, and PBL, respectively) were digested with BamHI. The
Southern blot was hybridized with the XhoI 1.9-kb probe for the
EBV right-terminal fragment.
epithelial cells and lymphoblastoid cells transformed by
virus from B95-8 cells (32). In A2L/AH cells, a single 16.9-kb
fused terminal BamHI fragment, containing approximately
17 TR, and a ladder of linear termini were identified. The
fused termini detected in lymphoid cell lines established by
infection with A2L/AH virus ranged in size from size 8.9 to
22.4 kb (Fig. 5). Fused terminal BamHI fragments of this
size would contain approximately 3 to 30 copies of TR.
As described above, the RI template for NPC-KT virus
DNA apparently contains a single joined terminal fragment
of 9.4 kb representing four copies of TR (25). Upon entry
into cells, NPC-KT virus circularized to form fused termini
ranging in size from 8.4 to 10.4 kb, representing two to six
copies of TR. Similarly, although linear virion DNA was
synthesized in AG876 cells from a template containing 8
copies of TR, the virus circularized during transformation of
lymphoblastoid cells to generate episomal forms with fused
termini containing 4 to 12 copies of TR. The range of
episomal DNA produced by infection with A2L/AH virus,
produced from a template with 17 copies of TR, was more
heterogeneous and varied from 3 to 30 copies of TR. In each
case, the range of heterogeneity in TR in the cell lines
produced with the progeny virus reflected the number of TR
in the template DNA (n) and the number ofTR in some of the
progeny molecules increased to the near maximum (2n-2)
predicted from a linear, concatenated RI.
DISCUSSION
It is difficult to characterize the RI of the large herpesvirus
genomes (2, 13). The very large size of the genomes has
J. VIROL.






FIG. 5. Variation in numbers of EBV TR in A2L/AH cells and
cord blood lymphocytes transformed by virus from A2L/AH cells.
Cord blood lymphocytes were infected with virus from A2L/AH
cells and cultured for 4 weeks. Intracellular DNAs (2.5 ,utg) from
uninduced and IUdR-induced A2L/AH cells and from cord blood
lymphocytes transformed by virus from A2L/AH cells (lanes Non,
IUdR, and CBL, respectively) were digested with BamHI. A
Southern blot was prepared and hybridized with the XhoI 1.9-kb
probe for the EBV right-terminal fragment.
complicated analysis by electron microscopy, which de-
tected very large, tangled RI, without evidence of theta
structures (13). Similarly, analysis of sedimentation rates or
electrophoretic mobility reveals very large RI (2). During
replication of herpes simplex virus, terminal restriction
enzyme fragments cannot be identified (13). Failure to detect
termini suggests that the RI is a concatenated linear form
perhaps produced from a rolling circle. Alternatively, the RI
might be catenated, topologically linked circles.
The mechanism of EBV DNA replication during the
replicative cycle has also not been established. However,
unlike herpes simplex virus, which has direct repeat ele-
ments at the termini and inverted repeat elements which
generate multiple isomeric forms through recombination and
inversion, EBV does not isomerize and the TR are found
only at the termini (1, 7). This aspect of EBV DNA structure
allows for the identification of terminal fragments throughout
the replicative process. In the herpes simplex virus genome,
at least one copy of the reiterated a sequence is found at
each terminus in the mature progeny (20). Similarly, in EBV,
the most frequent cleavages retain at least one TR at each
end. The episomes that are formed with the progeny virus
from such cleavages contain at least two TR, with a likely
maximum of 2n-2.
There are two possible mechanisms for viral DNA repli-
cation from an episomal template. The circles can be nicked
to form either a rolling circle or a concatenated RI, or the
circle could directly replicate via a theta-shaped RI (15).
Whichever mechanism is invoked, one would expect to see
an increase in the abundance of the fused terminal restriction
fragment during replication. Either form of RI would be
expected to migrate as a very large molecule in a pulse-field
analysis.
In the theta model for the RI, the resident plasmids are
amplified by viral enzyme, and the newly synthesized cate-
nated circular genomes are cleaved to a linear form (28). In
this case, fused termini would represent circular DNA. In
the rolling-circle model, the fused termini would represent
DNA concatemers. Cleavage of both concatemers and cir-
cular intermediates, which may take place at different posi-
tions in the region of TR, generates a ladder of terminal
restriction fragments in linear DNA which are heteroge-
neous in size by increments of 500 bp. However, linear DNA
derived from concatemers would circularize to produce
fused termini containing both greater and fewer numbers of
TR. If the linear forms were derived from circular interme-
diates, circularization would form joint termini containing
the same numbers of TR as are in the fused terminus of
episomal DNA from which linear DNA is derived. If the
circular intermediates were cleaved at more than one site in
the region of TR, then circles formed after infection with the
virus could contain fewer total numbers of TR. The data
obtained in this study support the model that EBV DNA
replication which is mediated by the viral DNA polymerase
proceeds via linear concatemers as RI, perhaps by a rolling-
circle mechanism.
Recently, the EBV origin of DNA replication that func-
tions during lytic infection, termed orilyt, has been identified
(12). Replication that is mediated through orily, depends on
the EBV DNA polymerase and yields a concatemeric mol-
ecule (12). The data presented here suggests that the intact
viral genome also replicates via a concatenated RI. More-
over, the detection of non-CCC DNA which contains fused
termini with fewer copy numbers ofTR that are synthesized
from a homogeneous episomal template suggests that prog-
eny molecules may also form RI.
The terminal restriction enzyme fragments have been
previously identified in the prototype EBV-producer cell line
B95-8 (4, 23). These studies indicated that B95-8 contained at
least four fused terminal fragments and linear molecules with
heterogeneous termini (4, 23). The presence of multiple
fused termini in B95-8 could reflect the proliferation of
several EBV-infected clones or indicate that the original cell
was infected by more than one virion, resulting in circular-
ized intracellular EBV genomes with differing numbers of
TR. However, analysis of the immunoglobulin gene rear-
rangement indicated that the B95-8 cell line was monoclonal
(4). The data presented here indicate that the episomal DNA
in the B95-8 cell line is also clonal, with a homogeneous
number of TR, in agreement with the clonality indicated by
immunoglobulin gene rearrangement.
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